Minnesota Oncology

Breast Cancer News

Risk of Breast Cancer Recurrence Doesn’t Increase with TNF Inhibitor Use (August 28, 2014)

According to the results of a recently published study from Swedish investigators treatment with tumor necrosis factor inhibitors (TNF) does not appear to increase the rate of breast cancer recurrence among patients with rheumatoid arthritis (RA).  The... Continue Reading

Aromasin is New Treatment Option for Young Women With Hormone-sensitive Breast Cancer (August 19, 2014)

The results of a recently completed clinical study presented at the 2014 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago and now published online in the New England Journal of Medicine demonstrate that Aromasin® (exemestane), is... Continue Reading

Weighing the Risks (August 12, 2014)

Exploring the Link Between Obesity and Cancer By Kari Bohlke, ScD “For the great majority of Americans who do not use tobacco, weight control, dietary choices, and levels of physical activity are the most important modifiable determinants of cancer... Continue Reading

Recent Study Finds That African American Women Less Likely To Receive Standard Breast Cancer Treatment (July 7, 2014)

New research from the The University of Texas MD Anderson Cancer Center found that African American women diagnosed with early stage invasive breast cancer were 12 percent less likely than Caucasian women with the same diagnosis to receive axillary sentinel... Continue Reading

Zoladex Shows Fertility Advantages in Treatment of Early Breast Cancer (June 30, 2014)

At the 2014 American Society of Clinical Oncology® meeting in Chicago, researchers reported that women with early stage hormone receptor-negative (HR-negative) breast cancer who were treated with Zoladex® (goserelin) had a reduced rate of ovarian failure... Continue Reading

Aromasin Reduces Risk of Recurrence in Early Breast Cancer (June 25, 2014)

In a joint analysis of two clinical trials reported at the American Society of Clinical Oncologists meeting in Chicago, researchers found that premenopausal women undergoing hormone suppression and who were treated with Aromasin® (exemestane) had reduced... Continue Reading

Ask the Expert: Making Informed Decisions about Breast Reconstruction (June 18, 2014)

July 16, 2014 at 6:30pm EST CancerConnect live Web Chat with an Expert series presents:  “Making Informed Decisions about Breast Reconstruction.”  On July 16, 2014 at 6:30pm EST you will have the opportunity to engage with a breast cancer expert... Continue Reading

Tykerb and Herceptin Combination Therapy Fails to Improve Outcomes for Early Stage HER2 Breast Cancer (June 10, 2014)

Dr. Martine Piccart-Gebhart presented results at the 2014 annual meeting of the American Society of Clinical Oncology showing that a combination treatment of Tykerb® (lapatinib) and Herceptin® (trastuzumab) offered no benefit in outcomes for early stage... Continue Reading

Updated Guidelines for Adjuvant Tamoxifen in Hormone-Positive Breast Cancer (May 29, 2014)

The American Society of Clinical Oncology (ASCO) has updated their guidelines for the use of adjuvant endocrine therapy, particularly adjuvant tamoxifen (Nolvadex®), for women with hormone receptor-positive breast cancer. This update, which focuses on... Continue Reading

Ask the Expert: Breast Cancer, Diet and Exercise (May 19, 2014)

CancerConnect recently partnered with Dana-Farber to provide you with the opportunity to engage with a breast cancer expert, Jennifer A. Ligibel, MD, of the Susan F. Smith Center for Women’s Cancers at Dana-Farber. On May 7 and 8, 2014, Dr. Ligibel... Continue Reading

Latest Breast Cancer News By Stage


Carcinoma In Situ Breast cancer

Risk of Breast Cancer Recurrence Doesn’t Increase with TNF Inhibitor Use (August 28, 2014)

According to the results of a recently published study from Swedish investigators treatment with tumor necrosis factor inhibitors (TNF) does not appear to increase the rate of breast cancer recurrence among patients with rheumatoid arthritis (RA).  The... Continue Reading

Recent Study Finds That African American Women Less Likely To Receive Standard Breast Cancer Treatment (July 7, 2014)

New research from the The University of Texas MD Anderson Cancer Center found that African American women diagnosed with early stage invasive breast cancer were 12 percent less likely than Caucasian women with the same diagnosis to receive axillary sentinel... Continue Reading

Zoladex Shows Fertility Advantages in Treatment of Early Breast Cancer (June 30, 2014)

At the 2014 American Society of Clinical Oncology® meeting in Chicago, researchers reported that women with early stage hormone receptor-negative (HR-negative) breast cancer who were treated with Zoladex® (goserelin) had a reduced rate of ovarian failure... Continue Reading

Ask the Expert: Making Informed Decisions about Breast Reconstruction (June 18, 2014)

July 16, 2014 at 6:30pm EST CancerConnect live Web Chat with an Expert series presents:  “Making Informed Decisions about Breast Reconstruction.”  On July 16, 2014 at 6:30pm EST you will have the opportunity to engage with a breast cancer expert... Continue Reading

Tykerb and Herceptin Combination Therapy Fails to Improve Outcomes for Early Stage HER2 Breast Cancer (June 10, 2014)

Dr. Martine Piccart-Gebhart presented results at the 2014 annual meeting of the American Society of Clinical Oncology showing that a combination treatment of Tykerb® (lapatinib) and Herceptin® (trastuzumab) offered no benefit in outcomes for early stage... Continue Reading

More Carcinoma In Situ Breast cancer

Inflammatory Breast Cancer

Risk of Breast Cancer Recurrence Doesn’t Increase with TNF Inhibitor Use (August 28, 2014)

According to the results of a recently published study from Swedish investigators treatment with tumor necrosis factor inhibitors (TNF) does not appear to increase the rate of breast cancer recurrence among patients with rheumatoid arthritis (RA).  The... Continue Reading

Ask the Expert: Making Informed Decisions about Breast Reconstruction (June 18, 2014)

July 16, 2014 at 6:30pm EST CancerConnect live Web Chat with an Expert series presents:  “Making Informed Decisions about Breast Reconstruction.”  On July 16, 2014 at 6:30pm EST you will have the opportunity to engage with a breast cancer expert... Continue Reading

Ask the Expert: Breast Cancer, Diet and Exercise (May 19, 2014)

CancerConnect recently partnered with Dana-Farber to provide you with the opportunity to engage with a breast cancer expert, Jennifer A. Ligibel, MD, of the Susan F. Smith Center for Women’s Cancers at Dana-Farber. On May 7 and 8, 2014, Dr. Ligibel... Continue Reading

Reconstructive Breast Surgery On the Rise, but Influenced By Location (February 24, 2014)

More women are choosing reconstructive breast surgery after mastectomy; however, there is a large variation in the rate of reconstructive surgery throughout different areas of the United States, according to the results of a study published early online... Continue Reading

Compression Bandage As Effective As Lymphatic Massage for Lymphedema (December 13, 2013)

Lymphatic massage is no better than compression bandages for the treatment of lymphedema, according to the results of a study published in the Journal of Clinical Oncology. Lymphedema is the buildup of lymph fluid in the tissues just under the skin, resulting... Continue Reading

More Inflammatory Breast Cancer

Metastatic Breast Cancer

Ask the Expert: Breast Cancer, Diet and Exercise (May 19, 2014)

CancerConnect recently partnered with Dana-Farber to provide you with the opportunity to engage with a breast cancer expert, Jennifer A. Ligibel, MD, of the Susan F. Smith Center for Women’s Cancers at Dana-Farber. On May 7 and 8, 2014, Dr. Ligibel... Continue Reading

Mastectomy May Be Unnecessary in Stage IV Breast Cancer (March 13, 2014)

Mastectomy is unnecessary in many women with stage IV breast cancer—and in fact may even facilitate the spread of the disease, according to the results of a study presented at the 2013 San Antonio Breast Cancer Symposium. Mastectomy—surgical removal... Continue Reading

Reconstructive Breast Surgery On the Rise, but Influenced By Location (February 24, 2014)

More women are choosing reconstructive breast surgery after mastectomy; however, there is a large variation in the rate of reconstructive surgery throughout different areas of the United States, according to the results of a study published early online... Continue Reading

Higher Dose of Faslodex Effective in Advanced Breast Cancer (December 30, 2013)

The final results are in—and they show that 500 mg of Faslodex® (fulvestrant) provides a significant advantage in overall survival compared to 250 mg of the drug in postmenopausal women with locally advanced or metastatic estrogen receptor–positive... Continue Reading

Compression Bandage As Effective As Lymphatic Massage for Lymphedema (December 13, 2013)

Lymphatic massage is no better than compression bandages for the treatment of lymphedema, according to the results of a study published in the Journal of Clinical Oncology. Lymphedema is the buildup of lymph fluid in the tissues just under the skin, resulting... Continue Reading

More Metastatic Breast Cancer

Recurrent Breast Cancer

Risk of Breast Cancer Recurrence Doesn’t Increase with TNF Inhibitor Use (August 28, 2014)

According to the results of a recently published study from Swedish investigators treatment with tumor necrosis factor inhibitors (TNF) does not appear to increase the rate of breast cancer recurrence among patients with rheumatoid arthritis (RA).  The... Continue Reading

Ask the Expert: Making Informed Decisions about Breast Reconstruction (June 18, 2014)

July 16, 2014 at 6:30pm EST CancerConnect live Web Chat with an Expert series presents:  “Making Informed Decisions about Breast Reconstruction.”  On July 16, 2014 at 6:30pm EST you will have the opportunity to engage with a breast cancer expert... Continue Reading

Ask the Expert: Breast Cancer, Diet and Exercise (May 19, 2014)

CancerConnect recently partnered with Dana-Farber to provide you with the opportunity to engage with a breast cancer expert, Jennifer A. Ligibel, MD, of the Susan F. Smith Center for Women’s Cancers at Dana-Farber. On May 7 and 8, 2014, Dr. Ligibel... Continue Reading

(February 28, 2014)

The Society of Surgical Oncology and the American Society for Radiation Oncology have announced new surgical guidelines indicating that although negative margins (no ink on tumor) reduce the risk of local recurrence, wider margin widths do not significantly... Continue Reading

Reconstructive Breast Surgery On the Rise, but Influenced By Location (February 24, 2014)

More women are choosing reconstructive breast surgery after mastectomy; however, there is a large variation in the rate of reconstructive surgery throughout different areas of the United States, according to the results of a study published early online... Continue Reading

More Recurrent Breast Cancer

Screening/Prevention Breast Cancer

Risk of Breast Cancer Recurrence Doesn’t Increase with TNF Inhibitor Use (August 28, 2014)

According to the results of a recently published study from Swedish investigators treatment with tumor necrosis factor inhibitors (TNF) does not appear to increase the rate of breast cancer recurrence among patients with rheumatoid arthritis (RA).  The... Continue Reading

Weighing the Risks (August 12, 2014)

Exploring the Link Between Obesity and Cancer By Kari Bohlke, ScD “For the great majority of Americans who do not use tobacco, weight control, dietary choices, and levels of physical activity are the most important modifiable determinants of cancer... Continue Reading

Ask the Expert: Breast Cancer, Diet and Exercise (May 19, 2014)

CancerConnect recently partnered with Dana-Farber to provide you with the opportunity to engage with a breast cancer expert, Jennifer A. Ligibel, MD, of the Susan F. Smith Center for Women’s Cancers at Dana-Farber. On May 7 and 8, 2014, Dr. Ligibel... Continue Reading

Regular Physical Activity Reduces Risk of Breast Cancer (April 28, 2014)

An hour of daily physical activity reduces the risk of breast cancer, regardless of age or weight, according to the results of a study presented at the 2014 European Breast Cancer Conference in Glasgow, Scotland. Each year, roughly 227,000 women are diagnosed... Continue Reading

Reduced Mammography Screening for Breast Cancer Translates to Billions in Savings (February 18, 2014)

Reducing mammography screening frequency from annually to biennially among women aged 50 to 74 could save the healthcare system billions of dollars annually—and may actually allow physicians to end up screening more women compared with the current practice,... Continue Reading

More Screening/Prevention Breast Cancer

Stage I Node Negative Breast Cancer

Risk of Breast Cancer Recurrence Doesn’t Increase with TNF Inhibitor Use (August 28, 2014)

According to the results of a recently published study from Swedish investigators treatment with tumor necrosis factor inhibitors (TNF) does not appear to increase the rate of breast cancer recurrence among patients with rheumatoid arthritis (RA).  The... Continue Reading

Aromasin is New Treatment Option for Young Women With Hormone-sensitive Breast Cancer (August 19, 2014)

The results of a recently completed clinical study presented at the 2014 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago and now published online in the New England Journal of Medicine demonstrate that Aromasin® (exemestane), is... Continue Reading

Recent Study Finds That African American Women Less Likely To Receive Standard Breast Cancer Treatment (July 7, 2014)

New research from the The University of Texas MD Anderson Cancer Center found that African American women diagnosed with early stage invasive breast cancer were 12 percent less likely than Caucasian women with the same diagnosis to receive axillary sentinel... Continue Reading

Zoladex Shows Fertility Advantages in Treatment of Early Breast Cancer (June 30, 2014)

At the 2014 American Society of Clinical Oncology® meeting in Chicago, researchers reported that women with early stage hormone receptor-negative (HR-negative) breast cancer who were treated with Zoladex® (goserelin) had a reduced rate of ovarian failure... Continue Reading

Aromasin Reduces Risk of Recurrence in Early Breast Cancer (June 25, 2014)

In a joint analysis of two clinical trials reported at the American Society of Clinical Oncologists meeting in Chicago, researchers found that premenopausal women undergoing hormone suppression and who were treated with Aromasin® (exemestane) had reduced... Continue Reading

More Stage I Node Negative Breast Cancer

Stages II-III Breast Cancer

Risk of Breast Cancer Recurrence Doesn’t Increase with TNF Inhibitor Use (August 28, 2014)

According to the results of a recently published study from Swedish investigators treatment with tumor necrosis factor inhibitors (TNF) does not appear to increase the rate of breast cancer recurrence among patients with rheumatoid arthritis (RA).  The... Continue Reading

Aromasin is New Treatment Option for Young Women With Hormone-sensitive Breast Cancer (August 19, 2014)

The results of a recently completed clinical study presented at the 2014 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago and now published online in the New England Journal of Medicine demonstrate that Aromasin® (exemestane), is... Continue Reading

Recent Study Finds That African American Women Less Likely To Receive Standard Breast Cancer Treatment (July 7, 2014)

New research from the The University of Texas MD Anderson Cancer Center found that African American women diagnosed with early stage invasive breast cancer were 12 percent less likely than Caucasian women with the same diagnosis to receive axillary sentinel... Continue Reading

Zoladex Shows Fertility Advantages in Treatment of Early Breast Cancer (June 30, 2014)

At the 2014 American Society of Clinical Oncology® meeting in Chicago, researchers reported that women with early stage hormone receptor-negative (HR-negative) breast cancer who were treated with Zoladex® (goserelin) had a reduced rate of ovarian failure... Continue Reading

Aromasin Reduces Risk of Recurrence in Early Breast Cancer (June 25, 2014)

In a joint analysis of two clinical trials reported at the American Society of Clinical Oncologists meeting in Chicago, researchers found that premenopausal women undergoing hormone suppression and who were treated with Aromasin® (exemestane) had reduced... Continue Reading

More Stages II-III Breast Cancer

Supportive Care Breast Cancer

Risk of Breast Cancer Recurrence Doesn’t Increase with TNF Inhibitor Use (August 28, 2014)

According to the results of a recently published study from Swedish investigators treatment with tumor necrosis factor inhibitors (TNF) does not appear to increase the rate of breast cancer recurrence among patients with rheumatoid arthritis (RA).  The... Continue Reading

Ask the Expert: Making Informed Decisions about Breast Reconstruction (June 18, 2014)

July 16, 2014 at 6:30pm EST CancerConnect live Web Chat with an Expert series presents:  “Making Informed Decisions about Breast Reconstruction.”  On July 16, 2014 at 6:30pm EST you will have the opportunity to engage with a breast cancer expert... Continue Reading

Ask the Expert: Breast Cancer, Diet and Exercise (May 19, 2014)

CancerConnect recently partnered with Dana-Farber to provide you with the opportunity to engage with a breast cancer expert, Jennifer A. Ligibel, MD, of the Susan F. Smith Center for Women’s Cancers at Dana-Farber. On May 7 and 8, 2014, Dr. Ligibel... Continue Reading

Compression Bandage As Effective As Lymphatic Massage for Lymphedema (December 13, 2013)

Lymphatic massage is no better than compression bandages for the treatment of lymphedema, according to the results of a study published in the Journal of Clinical Oncology. Lymphedema is the buildup of lymph fluid in the tissues just under the skin, resulting... Continue Reading

Risk of Heart Disease from Breast Cancer Radiation Declines (November 27, 2013)

Although radiation exposure from breast cancer treatment is associated with a small risk of subsequent heart disease, the risk is lower than it was 20 years ago, according to the results of a study published early online in JAMA Internal Medicine. Approximately... Continue Reading

More Supportive Care Breast Cancer